Chapter 1.GLOBAL DYSTONIA DBS DEVICES MARKET – Scope & Methodology
1.1. Market Segmentation
1.2. Assumptions
1.3. Research Methodology
1.4. Primary Sources
1.5. Secondary Sources
Chapter 2.GLOBAL DYSTONIA DBS DEVICES MARKET – Executive Summary
2.1. Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.3. COVID-19 Impact Analysis
2.3.1. Impact during 2023 - 2030
2.3.2. Impact on Supply – Demand
Chapter 3.GLOBAL DYSTONIA DBS DEVICES MARKET – Competition Scenario
3.1. Market Share Analysis
3.2. Product Benchmarking
3.3. Competitive Strategy & Development Scenario
3.4. Competitive Pricing Analysis
3.5. Supplier - Distributor Analysis
Chapter 4.GLOBAL DYSTONIA DBS DEVICES MARKET - Entry Scenario
4.1. Case Studies – Start-up/Thriving Companies
4.2. Regulatory Scenario - By Region
4.3 Customer Analysis
4.4. Porter's Five Force Model
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Powers of Customers
4.4.3. Threat of New Entrants
4.4.4. Rivalry among Existing Players
4.4.5. Threat of Substitutes
Chapter 5. GLOBAL DYSTONIA DBS DEVICES MARKET - Landscape
5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities
Chapter 6.GLOBAL DYSTONIA DBS DEVICES MARKET – By Product Type:
6.1. Single-channel Deep Brain Stimulator
6.2. Dual-channel Deep Brain Stimulator
Chapter 7.GLOBAL DYSTONIA DBS DEVICES MARKET – By Region
7.1. North America
7.2. Europe
7.3. The Asia Pacific
7.4. Latin America
7.5. The Middle East
7.6. Africa
Chapter 8.GLOBAL DYSTONIA DBS DEVICES MARKET – Company Profiles – (Overview, Product Portfolio, Financials, Developments)
8.1. Boston Scientific Corporation
8.2. Medtronic Plc
8.3. Abbott Laboratories
8.4. NeuroPace Inc
8.5. Renishaw Plc
8.6. Beijing PINS Medical Co. Ltd
8.7. LivaNova PLC
8.8. Nexstim
8.9. Aleva Neurotherapeutics
8.10. St. Jude Medical
8.11. Sapiens Neuro
2850
5250
4500
1800
Frequently Asked Questions
The global Dystonia DBS Devices Market size is estimated to grow from USD 1.6 Billion in 2022 to USD 2.69 Billion by 2030. The market is witnessing a healthy CAGR of 6.7% from 2023 to 2030. An increase in the number of patients with epilepsy and Parkinson's disease is the major factor driving the industry's growth.
The Global Dystonia DBS Devices Market drivers are an increase in the number of patients with epilepsy and Parkinson's
The Segments under Global Dystonia DBS Devices Market segments by Product Type are Single-channel Deep Brain Stimulator and Dual-channel Deep Brain Stimulator.
North America is the most dominating region in the Global Dystonia DBS Devices Market
Boston Scientific Corporation, Medtronic Plc, and Abbott Laboratories are the leading players in the Global Dystonia DBS Devices Market.